IFNA1 and systemic lupus erythematosus: Even if most women with SLE had hydroxychloroquine treatment (91%), which is known to decrease the IFN signature strength and to reduce IFNα secretion by pDCs [38, 39], we found that about one third were IFNα protein positive.